Lyell shareholders elect Friedman, approve auditor, say-on-pay, and reverse split authorization up to 1-for-25

Lyell Immunopharma, Inc.

Class I director Catherine Friedman elected with 156.3M votes for (96.3% of votes cast).
Ratification of Ernst & Young as auditor approved: 212.0M for, 0.3M against.
Advisory say-on-pay passed with 160.7M votes for (99.0% of votes cast).
Reverse stock split authorization approved: 199.9M for (94.2% of votes cast), ratio range 1:10 to 1:25 at Board's discretion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.